With its comprehensive, global coverage of all aspects of diagnosis, screening, and treatment in both adults and children, Firestein & Kelley’s Textbook of Rheumatology remains your reference of choice in this evolving field. The fully revised 12th Edition retains the user-friendly, full color format, providing in-depth guidance in rheumatology with an ideal balance of basic science and clinical application. New editors, new chapters, and new illustrations keep you fully up to date on recent advances in genetics and the microbiome, current therapies, and other rapid changes in the field.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Preface - p. gxxv 8. List of Illustrations - p. gxxv 9. List of Tables - p. gxxv 10. Volume I - p. gxxv 11. Part 1: Structure and Function of Bone, Joints, and Connective Tissue - p. gxxv 12. Chapter 1: Developmental Biology, Organization, and Function of the Synovial Joints - p. gxxv 13. Chapter 2: Synovium - p. g18 14. Chapter 3: Cartilage and Chondrocytes - p. g32 15. Chapter 4: Development and Biology of Bone - p. g57 16. Chapter 5: Muscle Anatomy, Physiology, and Biochemistry - p. g69 17. Chapter 6: Biomechanics - p. g80 18. Chapter 7: Regenerative Medicine and Tissue Engineering - p. g96 19. Chapter 8: Proteinases and Matrix Degradation - p. g111 20. Part 2: Cells Involved in Autoimmune Diseases and Inflammation - p. g135 21. Chapter 9: Dendritic Cells - p. g135 22. Chapter 10: Mononuclear Phagocytes - p. g155 23. Chapter 11: Neutrophils - p. g168 24. Chapter 12: T Lymphocytes - p. g181 25. Chapter 13: B Cells - p. g199 26. Chapter 14: Fibroblasts and Fibroblast-like Synoviocytes - p. g223 27. Chapter 15: Mast Cells and Basophils - p. g243 28. Chapter 16: Innate Lymphoid Cells and Natural Killer Cells - p. g262 29. Chapter 17: Platelets and Megakaryocytes - p. g270 30. Part 3: Effector Mechanisms in Autoimmunity and Inflammation - p. g281 31. Chapter 18: Principles of Signaling - p. g281 32. Chapter 19: Innate Immunity - p. g296 33. Chapter 20: Adaptive Immunity - p. g311 34. Chapter 21: Immune Tolerance and Autoimmunity - p. g328 35. Chapter 22: Pre-clinical Autoimmunity - p. g349 36. Chapter 23: The Microbiome in Rheumatic Diseases - p. g359 37. Chapter 24: Genetics of Rheumatic Diseases - p. g376 38. Chapter 25: Epigenetics of Rheumatic Diseases - p. g391 39. Chapter 26: Complement System - p. g406 40. Chapter 27: Prostaglandins, Leukotrienes, and Related Compounds - p. g420 41. Chapter 28: Angiogenesis - p. g438 42. Chapter 29: Cytokines and Chemokines - p. g448 43. Chapter 30: Neuronal Mechanisms of Pain and Inflammation - p. g462 44. Part 4: Broad Issues in the Approach to Rheumatic Disease - p. g477 45. Chapter 31: Clinical Research Methods in the Rheumatic Diseases - p. g477 46. Chapter 32: Epidemiology and Impact of Rheumatic Diseases - p. g491 47. Chapter 33: Assessment of Health Outcomes - p. g498 48. Chapter 34: Biomarkers in Rheumatology - p. g511 49. Chapter 35: Occupational, Environmental, and Recreational Musculoskeletal Disorders - p. g527 50. Chapter 36: Cardiovascular Risk in Inflammatory Rheumatic Disease - p. g540 51. Chapter 37: Cancer Risk in Rheumatic Diseases - p. g557 52. Chapter 38: Occupational Therapy, Physical Therapy, and Rehabilitation - p. g571 53. Chapter 39: General Principles of Pregnancy and Rheumatic Disease: Pre-pregnancy Assessment - p. g583 54. Part 5: Evaluation of Generalized and Localized Symptoms - p. g600 55. Chapter 40: History and Physical Examination of the Musculoskeletal System - p. g600 56. Chapter 41: Ultrasound in Rheumatology - p. g620 57. Chapter 42: Evaluation of Monoarticular and Polyarticular Arthritis - p. g645 58. Chapter 43: Skin and Rheumatic Diseases - p. g659 59. Chapter 44: The Eye and Rheumatic Diseases - p. g683 60. Part 6: Differential Diagnosis of Regional and Diffuse Musculoskeletal Pain - p. g694 61. Chapter 45: Neck Pain - p. g694 62. Chapter 46: Shoulder Pain - p. g711 63. Chapter 47: Low Back Pain - p. g737 64. Chapter 48: Hip and Knee Pain - p. g760 65. Chapter 49: Foot and Ankle Pain - p. g778 66. Chapter 50: Hand and Wrist Pain - p. g788 67. Chapter 51: Temporomandibular Joint Disorders - p. g800 68. Chapter 52: Fibromyalgia - p. g812 69. Part 7: Diagnostic Tests and Procedures in Rheumatic Diseases - p. g827 70. Chapter 53: Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology - p. g827 71. Chapter 54: Arthrocentesis and Injection of Joints and Soft Tissues - p. g847 72. Chapter 55: Anti-nuclear Antibodies - p. g866 73. Chapter 56: Autoantibodies in Rheumatoid Arthritis - p. g881 74. Chapter 57: Acute Phase Reactants - p. g899 75. Chapter 58: Imaging in Rheumatic Diseases - p. g912 76. Volume II - p. g959 77. Part 8: Pharmacology of Anti-rheumatic Drugs - p. g959 78. Chapter 59: Therapeutic Targeting of Prostanoids - p. g959 79. Chapter 60: Glucocorticoid Therapy - p. g981 80. Chapter 61: Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies - p. g998 81. Chapter 62: Immunosuppressive Drugs - p. g1022 82. Chapter 63: Anti-cytokine Biologics - p. g1037 83. Chapter 64: Cell-Targeted Biologics and Emerging Targets: Rituximab, Abatacept, and Other Biologics - p. g1061 84. Chapter 65: Janus Kinase and Other Intra-cellular Targets - p. g1082 85. Chapter 66: Urate-Lowering Therapy - p. g1104 86. Chapter 67: Bisphosphonates - p. g1119 87. Chapter 68: Analgesic Agents in Rheumatic Disease - p. g1131 88. Chapter 69: Nutrition and Rheumatic Diseases - p. g1151 89. Part 9: Rheumatoid Arthritis and Sjögren’s Syndrome - p. g1162 90. Chapter 70: Etiology of Rheumatoid Arthritis - p. g1162 91. Chapter 71: Pathogenesis of Rheumatoid Arthritis - p. g1181 92. Chapter 72: Clinical Features of Rheumatoid Arthritis - p. g1220 93. Chapter 73: Treatment of Rheumatoid Arthritis - p. g1243 94. Chapter 74: Sjögren’s Syndrome - p. g1268 95. Part 10: Spondyloarthritis - p. g1294 96. Chapter 75: Classification and Epidemiology of Spondyloarthritis - p. g1294 97. Chapter 76: Axial Spondyloarthritis - p. g1306 98. Chapter 77: Reactive Arthritis - p. g1332 99. Chapter 78: Psoriatic Arthritis - p. g1345 100. Chapter 79: Inflammatory Bowel Disease–Associated Arthritis and Other Enteropathic Arthropathies - p. g1368 101. Part 11: Systemic Lupus Erythematosus and Related Syndromes - p. g1383 102. Chapter 80: Etiology and Pathogenesis of Systemic Lupus Erythematosus - p. g1383 103. Chapter 81: Clinical Features of Systemic Lupus Erythematosus - p. g1400 104. Chapter 82: Treatment of Systemic Lupus Erythematosus - p. g1426 105. Chapter 83: Antiphospholipid Syndrome - p. g1448 106. Part 12: Systemic Sclerosis, Inflammatory Myopathies, and Overlap Syndromes - p. g1463 107. Chapter 84: Etiology and Pathogenesis of Systemic Sclerosis - p. g1463 108. Chapter 85: Clinical Features and Treatment of Scleroderma - p. g1490 109. Chapter 86: Inflammatory Diseases of Muscle and Other Myopathies - p. g1529 110. Chapter 87: Overlap Syndromes - p. g1560 111. Part 13: Vasculitis - p. g1575 112. Chapter 88: Classification and Epidemiology of Systemic Vasculitis - p. g1575 113. Chapter 89: Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis - p. g1588 114. Chapter 90: Anti-neutrophil Cytoplasmic Antibody–Associated Vasculitis - p. g1612 115. Chapter 91: Polyarteritis Nodosa - p. g1631 116. Chapter 92: Immune Complex–Mediated Small Vessel Vasculitis - p. g1639 117. Chapter 93: Primary Central Nervous System Vasculitis - p. g1652 118. Chapter 94: Behçet’s Disease - p. g1659 119. Part 14: Crystal-Induced and Inflammasome-Mediated Inflammation - p. g1668 120. Chapter 95: Pathogenesis of Inflammasome-Mediated Diseases - p. g1668 121. Chapter 96: Etiology and Pathogenesis of Hyperuricemia and Gout - p. g1680 122. Chapter 97: Clinical Features and Treatment of Gout - p. g1704 123. Chapter 98: Calcium Crystal Disease: Calcium Pyrophosphate Deposition Disease and Basic Calcium Phosphate-Associated Syndromes - p. g1727 124. Chapter 99: Familial and Nonfamilial Autoinflammatory Syndromes - p. g1744 125. Part 15: Cartilage, Bone, and Heritable Connective Tissue Disorders - p. g1759 126. Chapter 100: Etiology and Pathogenesis of Osteoarthritis - p. g1759 127. Chapter 101: Clinical Features of Osteoarthritis - p. g1781 128. Chapter 102: Treatment of Osteoarthritis - p. g1795 129. Chapter 103: Metabolic Bone Disease - p. g1811 130. Chapter 104: Proliferative Bone Diseases - p. g1831 131. Chapter 105: Osteonecrosis - p. g1846 132. Chapter 106: Relapsing Polychondritis - p. g1872 133. Chapter 107: Heritable Diseases of Connective Tissues - p. g1883 134. Part 16: Rheumatic Diseases of Childhood - p. g1900 135. Chapter 108: Etiology and Pathogenesis of Juvenile Idiopathic Arthritis - p. g1900 136. Chapter 109: Clinical Features and Treatment of Juvenile Idiopathic Arthritis - p. g1909 137. Chapter 110: Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus - p. g1929 138. Chapter 111: Juvenile Dermatomyositis, Scleroderma, and Vasculitis - p. g1942 139. Part 17: Infections and Rheumatic Disease - p. g1972 140. Chapter 112: Bacterial Arthritis - p. g1972 141. Chapter 113: Lyme Disease - p. g1992 142. Chapter 114: Mycobacterial Infections of Bones and Joints - p. g2009 143. Chapter 115: Fungal Infections of Bones and Joints - p. g2023 144. Chapter 116: Rheumatic Manifestations of Human Immunodeficiency Virus Infection - p. g2033 145. Chapter 117: Viral Arthritis - p. g2048 146. Chapter 118: Rheumatic Fever and Post-streptococcal Arthritis - p. g2062 147. Chapter 119: COVID-19 and Rheumatic Disease - p. g2079 148. Chapter 120: Vaccination in Rheumatic Disease - p. g2092 149. Part 18: Arthritis Accompanying Systemic Disease - p. g2100 150. Chapter 121: Amyloidosis - p. g2100 151. Chapter 122: Sarcoidosis - p. g2114 152. Chapter 123: Hemochromatosis - p. g2131 153. Chapter 124: Hemophilic Arthropathy - p. g2142 154. Chapter 125: Rheumatic Manifestations of Hemoglobinopathies - p. g2155 155. Chapter 126: IgG4-Related Disease - p. g2165 156. Chapter 127: Arthritis Accompanying Endocrine and Metabolic Disorders - p. g2181 157. Chapter 128: Rheumatic Paraneoplastic Syndromes and Malignancies With Rheumatic Manifestations - p. g2193 158. Chapter 129: Tumors and Tumor-like Lesions of Joints and Related Structures - p. g2202 159. Chapter 130: Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer - p. g2226 160. Index - p. g2238 161. Chapter Acknowledgments - p. g2238 162. Chapter Acknowledgments - p. g2238
With its comprehensive, global coverage of all aspects of diagnosis, screening, and treatment in both adults and children, Firestein & Kelley’s Textbook of Rheumatology remains your reference of choice in this evolving field. The fully revised 12th Edition retains the user-friendly, full color format, providing in-depth guidance in rheumatology with an ideal balance of basic science and clinical application. New editors, new chapters, and new illustrations keep you fully up to date on recent advances in genetics and the microbiome, current therapies, and other rapid changes in the field.
1. Cover image - p. Cover 2. Title page - p. ii 3. Table of Contents - p. iii 4. Copyright - p. iii 5. Dedication - p. iii 6. Contributors - p. iii 7. Preface - p. gxxv 8. List of Illustrations - p. gxxv 9. List of Tables - p. gxxv 10. Volume I - p. gxxv 11. Part 1: Structure and Function of Bone, Joints, and Connective Tissue - p. gxxv 12. Chapter 1: Developmental Biology, Organization, and Function of the Synovial Joints - p. gxxv 13. Chapter 2: Synovium - p. g18 14. Chapter 3: Cartilage and Chondrocytes - p. g32 15. Chapter 4: Development and Biology of Bone - p. g57 16. Chapter 5: Muscle Anatomy, Physiology, and Biochemistry - p. g69 17. Chapter 6: Biomechanics - p. g80 18. Chapter 7: Regenerative Medicine and Tissue Engineering - p. g96 19. Chapter 8: Proteinases and Matrix Degradation - p. g111 20. Part 2: Cells Involved in Autoimmune Diseases and Inflammation - p. g135 21. Chapter 9: Dendritic Cells - p. g135 22. Chapter 10: Mononuclear Phagocytes - p. g155 23. Chapter 11: Neutrophils - p. g168 24. Chapter 12: T Lymphocytes - p. g181 25. Chapter 13: B Cells - p. g199 26. Chapter 14: Fibroblasts and Fibroblast-like Synoviocytes - p. g223 27. Chapter 15: Mast Cells and Basophils - p. g243 28. Chapter 16: Innate Lymphoid Cells and Natural Killer Cells - p. g262 29. Chapter 17: Platelets and Megakaryocytes - p. g270 30. Part 3: Effector Mechanisms in Autoimmunity and Inflammation - p. g281 31. Chapter 18: Principles of Signaling - p. g281 32. Chapter 19: Innate Immunity - p. g296 33. Chapter 20: Adaptive Immunity - p. g311 34. Chapter 21: Immune Tolerance and Autoimmunity - p. g328 35. Chapter 22: Pre-clinical Autoimmunity - p. g349 36. Chapter 23: The Microbiome in Rheumatic Diseases - p. g359 37. Chapter 24: Genetics of Rheumatic Diseases - p. g376 38. Chapter 25: Epigenetics of Rheumatic Diseases - p. g391 39. Chapter 26: Complement System - p. g406 40. Chapter 27: Prostaglandins, Leukotrienes, and Related Compounds - p. g420 41. Chapter 28: Angiogenesis - p. g438 42. Chapter 29: Cytokines and Chemokines - p. g448 43. Chapter 30: Neuronal Mechanisms of Pain and Inflammation - p. g462 44. Part 4: Broad Issues in the Approach to Rheumatic Disease - p. g477 45. Chapter 31: Clinical Research Methods in the Rheumatic Diseases - p. g477 46. Chapter 32: Epidemiology and Impact of Rheumatic Diseases - p. g491 47. Chapter 33: Assessment of Health Outcomes - p. g498 48. Chapter 34: Biomarkers in Rheumatology - p. g511 49. Chapter 35: Occupational, Environmental, and Recreational Musculoskeletal Disorders - p. g527 50. Chapter 36: Cardiovascular Risk in Inflammatory Rheumatic Disease - p. g540 51. Chapter 37: Cancer Risk in Rheumatic Diseases - p. g557 52. Chapter 38: Occupational Therapy, Physical Therapy, and Rehabilitation - p. g571 53. Chapter 39: General Principles of Pregnancy and Rheumatic Disease: Pre-pregnancy Assessment - p. g583 54. Part 5: Evaluation of Generalized and Localized Symptoms - p. g600 55. Chapter 40: History and Physical Examination of the Musculoskeletal System - p. g600 56. Chapter 41: Ultrasound in Rheumatology - p. g620 57. Chapter 42: Evaluation of Monoarticular and Polyarticular Arthritis - p. g645 58. Chapter 43: Skin and Rheumatic Diseases - p. g659 59. Chapter 44: The Eye and Rheumatic Diseases - p. g683 60. Part 6: Differential Diagnosis of Regional and Diffuse Musculoskeletal Pain - p. g694 61. Chapter 45: Neck Pain - p. g694 62. Chapter 46: Shoulder Pain - p. g711 63. Chapter 47: Low Back Pain - p. g737 64. Chapter 48: Hip and Knee Pain - p. g760 65. Chapter 49: Foot and Ankle Pain - p. g778 66. Chapter 50: Hand and Wrist Pain - p. g788 67. Chapter 51: Temporomandibular Joint Disorders - p. g800 68. Chapter 52: Fibromyalgia - p. g812 69. Part 7: Diagnostic Tests and Procedures in Rheumatic Diseases - p. g827 70. Chapter 53: Synovial Fluid Analyses, Synovial Biopsy, and Synovial Pathology - p. g827 71. Chapter 54: Arthrocentesis and Injection of Joints and Soft Tissues - p. g847 72. Chapter 55: Anti-nuclear Antibodies - p. g866 73. Chapter 56: Autoantibodies in Rheumatoid Arthritis - p. g881 74. Chapter 57: Acute Phase Reactants - p. g899 75. Chapter 58: Imaging in Rheumatic Diseases - p. g912 76. Volume II - p. g959 77. Part 8: Pharmacology of Anti-rheumatic Drugs - p. g959 78. Chapter 59: Therapeutic Targeting of Prostanoids - p. g959 79. Chapter 60: Glucocorticoid Therapy - p. g981 80. Chapter 61: Traditional DMARDs: Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine, and Combination Therapies - p. g998 81. Chapter 62: Immunosuppressive Drugs - p. g1022 82. Chapter 63: Anti-cytokine Biologics - p. g1037 83. Chapter 64: Cell-Targeted Biologics and Emerging Targets: Rituximab, Abatacept, and Other Biologics - p. g1061 84. Chapter 65: Janus Kinase and Other Intra-cellular Targets - p. g1082 85. Chapter 66: Urate-Lowering Therapy - p. g1104 86. Chapter 67: Bisphosphonates - p. g1119 87. Chapter 68: Analgesic Agents in Rheumatic Disease - p. g1131 88. Chapter 69: Nutrition and Rheumatic Diseases - p. g1151 89. Part 9: Rheumatoid Arthritis and Sjögren’s Syndrome - p. g1162 90. Chapter 70: Etiology of Rheumatoid Arthritis - p. g1162 91. Chapter 71: Pathogenesis of Rheumatoid Arthritis - p. g1181 92. Chapter 72: Clinical Features of Rheumatoid Arthritis - p. g1220 93. Chapter 73: Treatment of Rheumatoid Arthritis - p. g1243 94. Chapter 74: Sjögren’s Syndrome - p. g1268 95. Part 10: Spondyloarthritis - p. g1294 96. Chapter 75: Classification and Epidemiology of Spondyloarthritis - p. g1294 97. Chapter 76: Axial Spondyloarthritis - p. g1306 98. Chapter 77: Reactive Arthritis - p. g1332 99. Chapter 78: Psoriatic Arthritis - p. g1345 100. Chapter 79: Inflammatory Bowel Disease–Associated Arthritis and Other Enteropathic Arthropathies - p. g1368 101. Part 11: Systemic Lupus Erythematosus and Related Syndromes - p. g1383 102. Chapter 80: Etiology and Pathogenesis of Systemic Lupus Erythematosus - p. g1383 103. Chapter 81: Clinical Features of Systemic Lupus Erythematosus - p. g1400 104. Chapter 82: Treatment of Systemic Lupus Erythematosus - p. g1426 105. Chapter 83: Antiphospholipid Syndrome - p. g1448 106. Part 12: Systemic Sclerosis, Inflammatory Myopathies, and Overlap Syndromes - p. g1463 107. Chapter 84: Etiology and Pathogenesis of Systemic Sclerosis - p. g1463 108. Chapter 85: Clinical Features and Treatment of Scleroderma - p. g1490 109. Chapter 86: Inflammatory Diseases of Muscle and Other Myopathies - p. g1529 110. Chapter 87: Overlap Syndromes - p. g1560 111. Part 13: Vasculitis - p. g1575 112. Chapter 88: Classification and Epidemiology of Systemic Vasculitis - p. g1575 113. Chapter 89: Giant Cell Arteritis, Polymyalgia Rheumatica, and Takayasu’s Arteritis - p. g1588 114. Chapter 90: Anti-neutrophil Cytoplasmic Antibody–Associated Vasculitis - p. g1612 115. Chapter 91: Polyarteritis Nodosa - p. g1631 116. Chapter 92: Immune Complex–Mediated Small Vessel Vasculitis - p. g1639 117. Chapter 93: Primary Central Nervous System Vasculitis - p. g1652 118. Chapter 94: Behçet’s Disease - p. g1659 119. Part 14: Crystal-Induced and Inflammasome-Mediated Inflammation - p. g1668 120. Chapter 95: Pathogenesis of Inflammasome-Mediated Diseases - p. g1668 121. Chapter 96: Etiology and Pathogenesis of Hyperuricemia and Gout - p. g1680 122. Chapter 97: Clinical Features and Treatment of Gout - p. g1704 123. Chapter 98: Calcium Crystal Disease: Calcium Pyrophosphate Deposition Disease and Basic Calcium Phosphate-Associated Syndromes - p. g1727 124. Chapter 99: Familial and Nonfamilial Autoinflammatory Syndromes - p. g1744 125. Part 15: Cartilage, Bone, and Heritable Connective Tissue Disorders - p. g1759 126. Chapter 100: Etiology and Pathogenesis of Osteoarthritis - p. g1759 127. Chapter 101: Clinical Features of Osteoarthritis - p. g1781 128. Chapter 102: Treatment of Osteoarthritis - p. g1795 129. Chapter 103: Metabolic Bone Disease - p. g1811 130. Chapter 104: Proliferative Bone Diseases - p. g1831 131. Chapter 105: Osteonecrosis - p. g1846 132. Chapter 106: Relapsing Polychondritis - p. g1872 133. Chapter 107: Heritable Diseases of Connective Tissues - p. g1883 134. Part 16: Rheumatic Diseases of Childhood - p. g1900 135. Chapter 108: Etiology and Pathogenesis of Juvenile Idiopathic Arthritis - p. g1900 136. Chapter 109: Clinical Features and Treatment of Juvenile Idiopathic Arthritis - p. g1909 137. Chapter 110: Childhood-Onset Systemic Lupus Erythematosus, Drug-Induced Lupus in Children, and Neonatal Lupus - p. g1929 138. Chapter 111: Juvenile Dermatomyositis, Scleroderma, and Vasculitis - p. g1942 139. Part 17: Infections and Rheumatic Disease - p. g1972 140. Chapter 112: Bacterial Arthritis - p. g1972 141. Chapter 113: Lyme Disease - p. g1992 142. Chapter 114: Mycobacterial Infections of Bones and Joints - p. g2009 143. Chapter 115: Fungal Infections of Bones and Joints - p. g2023 144. Chapter 116: Rheumatic Manifestations of Human Immunodeficiency Virus Infection - p. g2033 145. Chapter 117: Viral Arthritis - p. g2048 146. Chapter 118: Rheumatic Fever and Post-streptococcal Arthritis - p. g2062 147. Chapter 119: COVID-19 and Rheumatic Disease - p. g2079 148. Chapter 120: Vaccination in Rheumatic Disease - p. g2092 149. Part 18: Arthritis Accompanying Systemic Disease - p. g2100 150. Chapter 121: Amyloidosis - p. g2100 151. Chapter 122: Sarcoidosis - p. g2114 152. Chapter 123: Hemochromatosis - p. g2131 153. Chapter 124: Hemophilic Arthropathy - p. g2142 154. Chapter 125: Rheumatic Manifestations of Hemoglobinopathies - p. g2155 155. Chapter 126: IgG4-Related Disease - p. g2165 156. Chapter 127: Arthritis Accompanying Endocrine and Metabolic Disorders - p. g2181 157. Chapter 128: Rheumatic Paraneoplastic Syndromes and Malignancies With Rheumatic Manifestations - p. g2193 158. Chapter 129: Tumors and Tumor-like Lesions of Joints and Related Structures - p. g2202 159. Chapter 130: Autoimmune Complications of Immune Checkpoint Inhibitors for Cancer - p. g2226 160. Index - p. g2238 161. Chapter Acknowledgments - p. g2238 162. Chapter Acknowledgments - p. g2238
